Executives
Dan Myers Appointed CEO of Leo Lens Pharma
Prior to joining Leo Lens Pharma, Dan Myers was the co-founder and Chief Executive Officer of Alimera Sciences, where he continues to serve as chairman of the Board of Directors.
Executives
CHPA Welcomes Procter & Gamble’s Paul Gama as Board Chair
Gama is President of Personal Health Care (PHC) for The Procter & Gamble Company (P&G), leading their global healthcare portfolio of OTC medicines, dietary supplements, and consumer medical devices.
Executives
Nathan Diers Promoted Vice President of EyeKor Product Development
Yijun Huang, CEO of EyeKor, is thrilled with this new promotion. Huang said, "Nathan has been an integral part of EyeKor's growth.
Executives
Charlie Alvarez Appointed Alliance Family of Companies CEO
Alvarez brings more than 30 years of healthcare leadership experience and most recently served as CEO of DCI Health Technologies, Inc.
Executives
David Long Named CFO of Cynosure
David Long will help accelerate the company's business transformation and growth plans under the new leadership of Chief Executive Officer and former Hershey and Unilever executive, Todd Tillemans.
Executives
Jay M. Moyes Appointed New CFO of Sera Prognostics
Jay Moyes joins Sera Prognostics as it transitions from rigorous scientific and groundbreaking clinical stage company into a rapidly growing commercial organization.
Executives
Roy Tanaka Joins S4 Medical’s Board of Directors
Roy Tanaka brings years of experience to S4. Tanaka joined Biosense Webster, a Johnson & Johnson company, in 1997 as U.S. president, and became its worldwide president in 2004 until his retirement in 2008.
Executives
Neil Tween Appointed CFO of Owlstone Medical
Neil Tween joins Owlstone Medical from GW Pharmaceuticals, a publicly listed (NASDAQ: GWPH) pharmaceutical company, where he served as Vice President and Group Financial Controller.
